#RegA+

2 articles tagged #RegA+ — curated RWA tokenization coverage.

Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform
Stocks

Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform

Mangoceuticals, a Nasdaq-listed telemedicine company, has announced a partnership with T7X to issue Series D Cumulative Convertible Preferred Stock natively on the Trusted Smart Chain. The company filed a Form 1-A offering statement with the SEC to raise up to $10 million by selling 1,000,000 shares at $10.00 each. This initiative marks a significant milestone as Mangoceuticals expects to become the first Nasdaq-listed firm to utilize the T7X platform for tokenized security issuance. The preferred stock features an 8% annual dividend and includes programmable compliance controls, such as KYC and AML, embedded directly into the blockchain protocol. By issuing these securities on-chain, the company aims to enhance settlement efficiency and transparency while limiting near-term dilution for common shareholders. The offering is structured under Regulation A, Tier 2, and requires final SEC qualification before proceeding. This development highlights the growing trend of public companies adopting native on-chain infrastructure to modernize capital formation and investor relations.

manilatimes.netAdded: Nov 19, 20268.0
T7X's On-Chain Capital Formation Model Validated by Tranquil Healthcare's SEC Reg A+ Qualification
Stocks

T7X's On-Chain Capital Formation Model Validated by Tranquil Healthcare's SEC Reg A+ Qualification

T7X has successfully facilitated the SEC qualification of a Regulation A+ offering for Tranquil Healthcare, marking a significant milestone for on-chain capital formation. This process allows Tranquil Healthcare to raise capital from both accredited and non-accredited investors through a tokenized framework. By leveraging T7X's infrastructure, the offering demonstrates how traditional securities regulations can be integrated with blockchain technology to streamline compliance and investor access. The qualification validates the viability of using on-chain models to meet rigorous SEC standards for public offerings. This development is crucial for the RWA market as it provides a repeatable blueprint for healthcare and other private firms to tokenize equity. It signals a shift toward broader institutional adoption of blockchain for capital raising, moving beyond simple asset representation to complex regulatory compliance. Ultimately, this integration bridges the gap between legacy financial markets and decentralized infrastructure, potentially lowering barriers for retail participation in private equity.

reuters.comAdded: Jul 30, 20267.5

Insights directly to your inbox

Get our daily curated analysis on real world asset tokenization.

No spam, unsubscribe anytime.